- $42.46bn
- $42.34bn
- $3.19bn
- 88
- 6
- 100
- 71
Annual balance sheet for Teradyne, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,366 | 894 | 820 | 600 | 322 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 551 | 491 | 422 | 471 | 774 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,576 | 2,258 | 2,162 | 1,816 | 1,936 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 456 | 492 | 519 | 578 | 640 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,809 | 3,501 | 3,487 | 3,709 | 4,170 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 805 | 746 | 660 | 625 | 1,102 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,245 | 1,050 | 961 | 889 | 1,375 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 2,564 | 2,451 | 2,526 | 2,819 | 2,796 |
| Total Liabilities & Shareholders' Equity | 3,809 | 3,501 | 3,487 | 3,709 | 4,170 |
| Total Common Shares Outstanding |